日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Oncogenic gene fusions in cancer: from biology to therapy

癌症中的致癌基因融合:从生物学到治疗

Liu, Stephen V; Nagasaka, Misako; Atz, Judith; Solca, Flavio; Müllauer, Leonhard

Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1)

阿法替尼治疗ERBB1-3基因改变的晚期尿路上皮癌患者的II期试验(LUX-Bladder 1)

Font, Albert; Mellado, Begona; Climent, Miguel A; Virizuela, Juan Antonio; Oudard, Stephane; Puente, Javier; Castellano, Daniel; González-Del-Alba, Aranzazu; Pinto, Alvaro; Morales-Barrera, Rafael; Rodriguez-Vida, Alejo; Fernandez, Pedro L; Teixido, Cristina; Jares, Pedro; Aldecoa, Iban; Gibson, Neil; Solca, Flavio; Mondal, Shoubhik; Lorence, Robert M; Serra, Josep; Real, Francisco X

Genomic Analysis of Tumors from Patients with Glioblastoma with Long-Term Response to Afatinib

对接受阿法替尼治疗后长期有效的胶质母细胞瘤患者的肿瘤进行基因组分析

Owen, Scott; Alken, Scheryll; Alshami, Jad; Guiot, Marie-Christine; Kavan, Petr; Reardon, David A; Muanza, Thierry; Gibson, Neil; Pemberton, Karine; Solca, Flavio; Cseh, Agnieszka; Saran, Frank

Therapeutic Potential of Afatinib in NRG1 Fusion-Driven Solid Tumors: A Case Series

阿法替尼在NRG1融合驱动的实体瘤中的治疗潜力:病例系列研究

Cadranel, Jacques; Liu, Stephen V; Duruisseaux, Michaël; Branden, Eva; Goto, Yasushi; Weinberg, Benjamin A; Heining, Christoph; Schlenk, Richard F; Cheema, Parneet; Jones, Martin R; Drilon, Alexander; Trombetta, Domenico; Muscarella, Lucia Anna; Tolba, Khaled; Gounant, Valerie; Cseh, Agnieszka; Solca, Flavio; Laskin, Janessa J; Renouf, Daniel J

Antitumor Activity of the IGF-1/IGF-2-Neutralizing Antibody Xentuzumab (BI 836845) in Combination with Enzalutamide in Prostate Cancer Models

IGF-1/IGF-2中和抗体Xentuzumab(BI 836845)联合恩扎卢胺在前列腺癌模型中的抗肿瘤活性

Weyer-Czernilofsky, Ulrike; Hofmann, Marco H; Friedbichler, Katrin; Baumgartinger, Rosa; Adam, Paul J; Solca, Flavio; Kraut, Norbert; Nguyen, Holly M; Corey, Eva; Liu, Gang; Sprenger, Cynthia C; Plymate, Stephen R; Bogenrieder, Thomas

Correction to: Afatinib is active in osteosarcoma cell lines

更正:阿法替尼对骨肉瘤细胞系有活性

Cruz-Ramos, Marlid; Zamudio-Cuevas, Yessica; Medina-Luna, Daniel; Martínez-Flores, Karina; Martínez-Nava, Gabriela; Fernández-Torres, Javier; López-Reyes, Alberto; Solca, Flavio

Afatinib is active in osteosarcoma in osteosarcoma cell lines.

阿法替尼对骨肉瘤细胞系中的骨肉瘤有活性

Cruz-Ramos Marlid, Zamudio-Cuevas Yessica, Medina-Luna Daniel, Martínez-Flores Karina, Martínez-Nava Gabriela, Fernández-Torres Javier, López-Reyes Alberto, Solca Flavio

Association of ERBB Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma: Secondary Analysis of the LUX-Lung 8 Randomized Clinical Trial

ERBB 突变与接受阿法替尼或厄洛替尼治疗的肺鳞状细胞癌患者临床结局的相关性:LUX-Lung 8 随机临床试验的二次分析

Goss, Glenwood D; Felip, Enriqueta; Cobo, Manuel; Lu, Shun; Syrigos, Konstantinos; Lee, Ki Hyeong; Göker, Erdem; Georgoulias, Vassilis; Li, Wei; Guclu, Salih; Isla, Dolores; Min, Young Joo; Morabito, Alessandro; Ardizzoni, Andrea; Gadgeel, Shirish M; Fülöp, Andrea; Bühnemann, Claudia; Gibson, Neil; Krämer, Nicole; Solca, Flavio; Cseh, Agnieszka; Ehrnrooth, Eva; Soria, Jean-Charles

Non-reproducible sequence artifacts in FFPE tissue: an experience report

FFPE组织中不可重复的序列伪影:经验报告

Ofner, Richard; Ritter, Cathrin; Ugurel, Selma; Cerroni, Lorenzo; Stiller, Mathias; Bogenrieder, Thomas; Solca, Flavio; Schrama, David; Becker, Jürgen C

Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo

阿法替尼在体外和体内对头颈部鳞状细胞癌细胞系的疗效

Young, Natalie R; Soneru, Christian; Liu, Jing; Grushko, Tatyana A; Hardeman, Ashley; Olopade, Olufunmilayo I; Baum, Anke; Solca, Flavio; Cohen, Ezra E W